Asthma related to Alternaria sensitization: An analysis of skin-test and serum-specific IgE efficiency based on the bronchial provocation test

Clinical and Experimental Allergy

Volumn 41, Issue 5, 2011, Pages 649-656

  Fernandez Rodriguez C ^a   Bevilacqua, E ^a   Fernandez N ^a   Gajate, P ^a   de la Camara A G ^b   Garcimartin M ^a   Vives, R ^a   Rodriguez J ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b Hospital Universitario   (Spain)

Author keywords

Allergic asthma; Alternaria serum specific IgE; Alternaria skin tests; Logistic regression; ROC curve

Indexed keywords

IMMUNOGLOBULIN E;

ADOLESCENT; ADULT; ALLERGIC ASTHMA; ALTERNARIA; ARTICLE; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PRICK TEST; PRIORITY JOURNAL; PROVOCATION TEST; SENSITIVITY AND SPECIFICITY; SENSITIZATION; SKIN TEST;

ADOLESCENT; ALTERNARIA; ASTHMA; BRONCHIAL PROVOCATION TESTS; FEMALE; HUMANS; IMMUNOGLOBULIN E; MALE; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; SKIN TESTS; YOUNG ADULT;

EID: 79954461877     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2010.03645.x     Document Type: Article

References (31)

1. D'Amato G, Chatzigeorgius G, Corsico R et al. Evaluation of the prevalence of skin prick test positive to Alternaria and Cladosporium in patients with suspected respiratory allergy: a European multicenter study promoted by the Subcommittee on Aerobiology and Environmental Aspects of Inhalant Allergens of the European Academy of Allergology and Clinical Immunology. Allergy 1997; 52:711-6.
2. Yunginger JW, Ahlstedt S, Eggleston P et al. Quantitative IgE antibody assays in allergic diseases. J Allergy Clin Immunol 2000; 105:1077-84.
3. Perzanowski M, Sporik R, Squillace S et al. Association of sensitization to Alternaria allergens with asthma among school-age children. J Allergy Clin Immol 1998; 101:626-32.
4. Eggleston P, Rosenstreich D, Lynn H et al. Relationship of indoor allergen exposure to skin tests sensitivity in inner city asthma. J Allergy Clin Immunol 1998; 102:563-70.
5. O'Hollaren M, Yunginger J, Offord K et al. Exposure to an aeroallergen as possible precipitating factor in respiratory arrest in young patients with asthma. N Engl J Med 1991; 324:359-63.
6. Neukirch C, Henry C, Leynaert B, Liard R, Bousquet J, Neukirch F. Is sensitization to Alternaria alternata a risk factor for severe asthma? A population-based study. J Allergy Clin Immunol 1999; 103:709-11.
7. Zureik M, Neukirch C, Leynaert B, Liard R, Bousquet J, Neukirch F. Sensitization to airbone moulds and severity of asthma: cross sectional study from European Community respiratory health survey. BMJ 2002; 325:411-23.
8. Black PN, Udy AA, Brodie SM. Sensitivity to fungal allergens is a risk factor for life-threatening asthma. Allergy 2000; 55:501-4.
9. Bush RK, Prochnau JJ. Alternaria-induced asthma. J Allergy Clin Immunol 2004; 113:227-34.
10. Esch RE, Bush RK. Aerobiology of outdoor allergens. In: Adkinson NF, Bochner BS, Busse WW, Holgate ST, Lemanske RF Jr, Simons FE, eds. Middleton's Allergy Principles and Practice, 7th Edn. Philadelphia: Mosby, 2009; 509-38.
11. Hong SG, Cramer RA, Lawrence CB, Pryor BM. Alt a 1 allergen homolog's from Alternaria and related taxa: analysis of phylogenetic content and secondary structure. Fungal Genet Biol 2005; 42:119-29.
12. Sáenz-Santamaria M, Postigo I, Gutiérrez-Rodríguez A, Cardona G, Guisantes JA, Asturias J. The major allergen of Alternaria alternata (Alt a 1) is expressed in other members of the Pleosporaceae family. Mycoses 2006; 49:91-5.
13. Roberts G, Lack G. Diagnosing peanut allergy with skin prick and specific IgE testing. J Allergy Clin Immunol 2005; 115:1291-6.
14. Fernández C, Cárdenas R, Martín D et al. Analysis of skin testing and serum-specific immunoglobulin E to predict airway reactivity to cat allergens. Clin Exp Allergy 2007; 37:391-99.
15. Melillo G, Bonini S, Cocco G et al. Provocation tests with allergens. Allergy 1997; 52:5-36.
16. National Heart, Lung, and Blood Institute Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, NIH Publication No. 02-3659 National Heart, Lung, and Blood Institute, Washington, 2002.
17. Bernstein IL, Li JT, Bernstein DI et al. American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology. Allergy diagnostic testing: an updated practice parameter. Ann Allergy Asthma Immunol 2008; 100 (Suppl 3):S1-148.
18. Malling H-J. Methods of skin testing. In: Dreborg S, ed. Skin tests used in type I allergy testing, Position paper of the European Academy of Allergology and Clinical Immunology. Allergy 1989;44:55-6.
19. Yan K, Salome C, Woolcock J. Rapid method for measurement of bronchial responsiveness. Thorax 1983; 38:760-5.
20. Chai H, Farr RS, Froehlich LA et al. Standardization of bronchial challenge procedures. J Allergy Clin Immunol 1975; 56:323-7.
21. Christensen LH, Holm J, Lund G, Riise E, Lund K. Several distinct properties of the IgE repertorie determine effector cell degranulation in response to allergen challenge. J Allergy Clin Immunol 2008; 122:298-304.
22. Gieras A, Focke-Tejkl M, Ball T et al. Molecular determinants of allergen-induced effector cell degranulation. J Allergy Clin Immunol 2007; 119:384-90.
23. Bush R, Portnoy J. The role and abatement of fungal allergens in allergic diseases. J Allergy Clin Immunol 2001; 107:430-40.
24. Gergen PJ, Turkeltaub PC. The association of individual allergen reactivity with respiratory disease in a national sample: data from the second National Health and Nutrition Examination Survey 1976-80 (NHAHES II). J Allergy Clin Immnol 1992; 90:579-88.
25. Kauffman H, Tomee C, van de Riet M, Timmerman A, Borger P. Protease-dependent activation of epithelial cells by fungal allergens leads to morphologic changes and cytokine production. J Allergy Clin Immunol 2000; 105:1185-93.
26. Kita H, Reed CE, Weiler CR. Protease-activated pathways of inflammation. In: Adkinson NF, Bochner BS, Busse WW, Holgate ST, Lemanske RF Jr, Simons FE, eds. Middleton's allergy principles and practice, 7th Edn. Philadelphia: Mosby, 2009; 423-35.
27. Kheradmand F, Kiss A, Xu J, Lee S, Kolattukudy P, Corry D. A protease-activated pathway underlying Th cell type 2 activation and allergic lung disease. J Immunol 2002; 169:5904-11.
28. Targonski PV, Persky VW, Ramekrishnan V. Effect of environmental molds on risk of death from asthma during the pollen season. J Allergy Clin Immunol 1995; 95:955-61.
29. Pulimood TB, Corden JM, Bryden CMA, Sharples L, Nasser SM. Epidemic asthma and the role of the fungal mold Alternaria alternata. J Allergy Clin Immunol 2007; 120:610-7.
30. Horst M, Hejjaoui A, Horst V et al. Y Double-blind, placebo-controlled rush immunotherapy with a stardandized Alternaria extract. J Allergy Clin Immunol 1990; 85:460-72.
31. Tabar AI, Lizaso MT, García BE et al. Double-blind, placebo-controlled study of Alternaria alternata immunotherapy: clinical efficacy and safety. Pediatr Allergy Immunol 2008; 19:67-75.